Leidos has been awarded a prime vaccine adjuvant development contract by the National Institute of Allergy and Infectious Diseases , part of the National Institutes of Health , to improve the efficacy of vaccine candidates for prevention of anthrax and West Nile virus disease.
http://www.contractpharma.com/contents/view_breaking-news/2013-11-04/leidos-awarded-nih-contract/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+ContractPharmaBreakingNews+%28Contract+Pharma+Breaking+News%29
http://www.contractpharma.com/contents/view_breaking-news/2013-11-04/leidos-awarded-nih-contract/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+ContractPharmaBreakingNews+%28Contract+Pharma+Breaking+News%29
No comments:
Post a Comment